Malignant external otitis: The diagnostic value of bone scintigraphy.

Ostfeld, Ervin; Aviel, Aharon; Pelet, Deborah

doi:10.1288/00005537-198106000-00014

Cited by 23 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Bone scans with gallium-67 (Ga67) or methylene diphosphonate-technetium-99m (Tc99m) were advocated for early stages and follow-up of SBO [33][34][35]. Tc99m detects osteoblastic activity and is highly sensitive for diagnosis but it is less specific and also found in malignant and traumatic diseases [36][37][38].…”

Section: Imagingmentioning

confidence: 99%

Current management of skull base osteomyelitis

Auinger¹,

Arnoldner²

2021

Current Opinion in Otolaryngology &Amp; Head &Amp; Neck Surgery

View full text Add to dashboard Cite

Purpose of review Skull base osteomyelitis (SBO) is a life-threatening condition. Due to an aging and increasingly multimorbid population, clinicians are more often challenged with this disease. Yet, there is no consensus on the optimal diagnostic and follow-up management. This review should aid clinicians in decision-making for their patients. Recent findings Treatment-resistant otalgia or headache is suspicious of SBO. Pseudomonas aeruginosa remains the most common pathogen but clinicians are challenged with increasing rates of sterile or fungal cultures due to previously applied antibiotics/steroids. No single imaging modality is able to detect the full extent of the disease. Whereas functional nuclear imaging with gallium-67 or methylene diphosphonate-technetium-99m was once advocated, its actual benefit is questionable. Newer modalities such as fluoro-D-glucose-positron emission tomography (PET)/computed tomography, PET/magnetic resonance imaging (MRI), or diffusion-weighted MRI seem to be promising in diagnosis and follow-up. Finding the causative pathogen is of utmost importance followed by long-term intravenous antibiotics until the disease has completely resolved. Surgery plays a minor role in treatment but can be helpful in selected cases. Summary The numerous challenges in SBO render management difficult, but with a clear work-up including regular clinical, laboratory and imaging examinations, outcome can be improved.

show abstract

Section: Imagingmentioning

confidence: 99%

Current management of skull base osteomyelitis

Auinger¹,

Arnoldner²

2021

Current Opinion in Otolaryngology &Amp; Head &Amp; Neck Surgery

View full text Add to dashboard Cite

show abstract

“…Cancer of the external auditory canal (EAC), the middle ear (ME) and the mastoid is fortunately rare. Its incidence has been estimated as 1 case per every 5000 -20,000 patients admitted to hospitals with otological diseases [3]- [5] or as 6 cases per million in the general population [6]. Squamous cell carcinoma accounts for the most common histologic type in this region, occurring in more than 80% of cases [7] [8].…”

Section: Introductionmentioning

confidence: 99%

Squamous Cell Carcinoma of the Middle Ear Mimicking CSOM with Intracranial Complications: A Diagnostic Dilemma

Attakkil¹,

Thorawade²,

Jagade³

et al. 2014

IJOHNS

View full text Add to dashboard Cite

Cancer of the external auditory canal (EAC) and middle ear (ME) is rare, accounting for less than 1% of all head-and-neck malignancies [1] [2] of which squamous cell carcinoma (SCC) is the most common. Even though squamous cell carcinoma [SCC] of the middle ear and chronic suppurative otitis media (CSOM) co-exist, no definitive correlation has been proven. Here we are presenting a case of squamous cell carcinoma of the middle ear who presented with headache, fever and vomiting with a background history of chronic suppurative otitis media since childhood. A provisional diagnosis of mastoid abscess with intracranial complications secondary to chronic suppurative otitis media was made and modified radical mastoidectomy was done but histology of the mastoid specimen revealed well differentiated keratinizing squamous cell carcinoma, which was treated with radical radiotherapy. Objective of this presentation is to bring attention to the coexistence of CSOM and squamous cell carcinoma ear and also the importance to detect these lesions at an early stage. This report also highlights the requirement of histopathological analysis in mastoidectomy and discusses the aetiology and management of squamous cell carcinoma of the middle ear with review of literature.

show abstract